MicrobeWorld App


Microbes After Hours


Click for more "Microbes After Hours" videos

Join MicrobeWorld

Subscribe via Email


Featured Image

Featured Video

Ebola Virus explained


ASM House 200X200

Triple-Drug Regimen Preferable for Treating H. Pylori

he standard 14-day triple-drug regimen is more effective for treating Helicobacter pylori (H. pylori) infection in Latin America than newer four-drug regimens, according to a study published online July 20 in The Lancet.

E. Robert Greenberg, M.D., of the Southwest Oncology Group Statistical Center -- Cancer Research and Biostatistics in Seattle, and colleagues compared the standard triple-drug regimen for treating H. pylori infection with concomitant and sequential four-drug regimens in seven cities in Latin America. A total of 1,463 patients between the ages of 21 and 65 years who tested positive for H. pylori by a urea breath test between September 2009 and June 2010 were randomly assigned to receive one of the following treatments: standard therapy (14 days of lansoprazole, amoxicillin, and clarithromycin; 488 patients), concomitant therapy (five days of lansoprazole, amoxicillin, clarithromycin, and metronidazole; 489 patients), and sequential therapy (five days of lansoprazole and amoxicillin followed by five days of lansoprazole, clarithromycin, and metronidazole; 486 patients). The primary outcome was the probability of H. pylori eradication, evaluated by urea breath test six to eight weeks after treatment.

Comments (0)

Collections (0)


American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use